CLOSE X
GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.68 0.08(0.28%) NAV as on 25 Nov 2025
-0.9 % 1 M
1.57 % 1 Y
21.76 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.10

As on 31 Oct, 2025
age-icon Age :

9 yrs 10 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,324.90 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

7.96

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 1.50 %
Equity 98.50 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.59 %
Apollo Hospitals Enterprise Ltd.5.13 %
Healthcare Global Enterprises...4.96 %
Lupin Ltd.4.90 %
Max Healthcare Institute Ltd.4.71 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs61.23
Hospital & Healthcare Services33.30
Pesticides & Agrochemicals2.17
Business Support1.76
Medical Equipment/Supplies/Accessories0.03
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)14.7317.1815.8825.0628.64
Net Assets(Rs Crores) (as on 31-Mar-2025) 435.03 553.33 493.44 878.70 1183.65
Scheme Returns(%)(Absolute)67.2416.04-7.3157.4613.01
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7541/7567/7619/9020/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.680.08(0.28%)NAV As on 25 Nov, 202528-Dec-2015Inception Date1,324.90AUM In Cr.1.57%1Y21.76%3Y17.27%5Y11.97%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity287.600.59(0.21%)NAV As on 25 Nov, 202501-Aug-2005Inception Date1,124.88AUM In Cr.0.82%1Y23.63%3Y17.06%5Y17.96%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity39.620.10(0.26%)NAV As on 25 Nov, 202530-Nov-2018Inception Date3,143.91AUM In Cr.-4.15%1Y21.11%3Y17.27%5Y21.76%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors